Chonghui Hu

545 total citations
11 papers, 354 citations indexed

About

Chonghui Hu is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Chonghui Hu has authored 11 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Chonghui Hu's work include Pancreatic and Hepatic Oncology Research (7 papers), MicroRNA in disease regulation (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). Chonghui Hu is often cited by papers focused on Pancreatic and Hepatic Oncology Research (7 papers), MicroRNA in disease regulation (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). Chonghui Hu collaborates with scholars based in China. Chonghui Hu's co-authors include Shangyou Zheng, Qing Lin, Renpeng Xia, Zhihua Li, Yuancheng Ye, Rufu Chen, Quanbo Zhou, Guolin Li, Xiang Zhang and Tingting Li and has published in prestigious journals such as Cancer Research, Oncogene and Molecular Cancer.

In The Last Decade

Chonghui Hu

10 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chonghui Hu China	9	243	183	140	70	23	11	354
Yafei Dai China	8	276 1.1×	269 1.5×	100 0.7×	53 0.8×	17 0.7×	8	408
Yongchu Sun China	9	194 0.8×	135 0.7×	99 0.7×	33 0.5×	39 1.7×	14	313
Yue‐Ju Li Taiwan	9	243 1.0×	174 1.0×	71 0.5×	29 0.4×	21 0.9×	11	326
Yi‐Chen Yen Taiwan	9	316 1.3×	171 0.9×	68 0.5×	41 0.6×	20 0.9×	11	405
Zeli Yin China	8	217 0.9×	199 1.1×	100 0.7×	84 1.2×	62 2.7×	11	371
Haijiao Yan China	11	343 1.4×	302 1.7×	128 0.9×	33 0.5×	35 1.5×	23	466
Jiaolong Shi China	7	248 1.0×	166 0.9×	80 0.6×	78 1.1×	70 3.0×	8	350
Wanli Ge China	12	309 1.3×	251 1.4×	83 0.6×	39 0.6×	36 1.6×	18	392
Corinna U. Brehm Germany	4	147 0.6×	86 0.5×	170 1.2×	97 1.4×	39 1.7×	6	326
Jian-Ping Huo China	6	157 0.6×	118 0.6×	104 0.7×	79 1.1×	45 2.0×	6	271

Countries citing papers authored by Chonghui Hu

Since Specialization

Citations

This map shows the geographic impact of Chonghui Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chonghui Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chonghui Hu more than expected).

Fields of papers citing papers by Chonghui Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chonghui Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chonghui Hu. The network helps show where Chonghui Hu may publish in the future.

Co-authorship network of co-authors of Chonghui Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Chonghui Hu. A scholar is included among the top collaborators of Chonghui Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chonghui Hu. Chonghui Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Hu, Chonghui, et al.. (2025). Cancer-Associated Fibroblasts Foster a High-Lactate Microenvironment to Drive Perineural Invasion in Pancreatic Cancer. Cancer Research. 85(12). 2199–2217. 11 indexed citations

Huang, Tianhao, Chonghui Hu, Huimou Chen, et al.. (2025). Lactylation-driven NSUN2 -mediated RNA m5C modification promotes perineural invasion in pancreatic cancer. Theranostics. 16(4). 1782–1803.

Hu, Chonghui, Yuan Yuan, Tingting Li, et al.. (2025). Glycolysis reprogramming in CAFs promotes oxaliplatin resistance in pancreatic cancer through circABCC4 mediated PKM2 nuclear translocation. Cell Death and Disease. 16(1). 126–126. 15 indexed citations

Xia, Renpeng, Chonghui Hu, Yuancheng Ye, et al.. (2023). HNF1A regulates oxaliplatin resistance in pancreatic cancer by targeting 53BP1. International Journal of Oncology. 62(4). 9 indexed citations

Zheng, Shangyou, Qing Tian, Yuan Yuan, et al.. (2023). Extracellular vesicle-packaged circBIRC6 from cancer-associated fibroblasts induce platinum resistance via SUMOylation modulation in pancreatic cancer. Journal of Experimental & Clinical Cancer Research. 42(1). 324–324. 30 indexed citations

Zheng, Shangyou, Chonghui Hu, Guolin Li, et al.. (2022). Cancer-associated fibroblast-induced lncRNA UPK1A-AS1 confers platinum resistance in pancreatic cancer via efficient double-strand break repair. Oncogene. 41(16). 2372–2389. 51 indexed citations

Zheng, Shangyou, Chonghui Hu, Guolin Li, et al.. (2022). circCUL2 induces an inflammatory CAF phenotype in pancreatic ductal adenocarcinoma via the activation of the MyD88-dependent NF-κB signaling pathway. Journal of Experimental & Clinical Cancer Research. 41(1). 71–71. 48 indexed citations

Hu, Chonghui, Renpeng Xia, Xiang Zhang, et al.. (2022). circFARP1 enables cancer-associated fibroblasts to promote gemcitabine resistance in pancreatic cancer via the LIF/STAT3 axis. Molecular Cancer. 21(1). 24–24. 107 indexed citations

Hu, Chonghui, et al.. (2021). A novel gene signature for prognosis prediction and chemotherapy response in patients with pancreatic cancer. Aging. 13(9). 12493–12513. 7 indexed citations

10.

Zhang, Bin, Huilin Ye, Shangyou Zheng, et al.. (2019). Macrophage-expressed CD51 promotes cancer stem cell properties via the TGF-β1/smad2/3 axis in pancreatic cancer. Cancer Letters. 459. 204–215. 56 indexed citations

11.

Wang, Zhen, Qiu Du, Zhiyong Chen, et al.. (2017). MicroRNA-524-5p Functions as a Tumor Suppressor in a Human Pituitary Tumor-Derived Cell Line. Hormone and Metabolic Research. 49(7). 550–557. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact